KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Current Assets: 2009-2024

Historic Current Assets for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Dec 2024 value amounting to $12.6 billion.

  • Teva Pharmaceutical Industries' Current Assets rose 3.43% to $12.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $12.7 billion, marking a year-over-year increase of 3.43%. This contributed to the annual value of $12.6 billion for FY2024, which is 0.54% up from last year.
  • Teva Pharmaceutical Industries' Current Assets amounted to $12.6 billion in FY2024, which was up 0.54% from $12.5 billion recorded in FY2023.
  • Over the past 5 years, Teva Pharmaceutical Industries' Current Assets peaked at $13.0 billion during FY2020, and registered a low of $12.1 billion during FY2022.
  • In the last 3 years, Teva Pharmaceutical Industries' Current Assets had a median value of $12.5 billion in 2023 and averaged $12.4 billion.
  • Per our database at Business Quant, Teva Pharmaceutical Industries' Current Assets dropped by 4.15% in 2022 and then increased by 3.60% in 2023.
  • Over the past 5 years, Teva Pharmaceutical Industries' Current Assets (Yearly) stood at $13.0 billion in 2020, then dropped by 3.32% to $12.6 billion in 2021, then fell by 4.15% to $12.1 billion in 2022, then increased by 3.60% to $12.5 billion in 2023, then rose by 0.54% to $12.6 billion in 2024.